CHRISTOPHER GIZA, M.D.
Pediatric Neurodevelopmental Disabilities Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: CHRISTOPHER GIZA, M.D. reported a CMS MIPS final score of 80.5085 out of 100, below the 83.1 national average, and filed 44 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
CHRISTOPHER GIZA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
CHRISTOPHER GIZA, M.D. at a glance
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Pediatric Neurodevelopmental Disabilities Physician compares to other specialties among California providers
Pediatric Neurodevelopmental Disabilities Physician share within California
Pediatric Neurodevelopmental Disabilities Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHRISTOPHER GIZA, M.D.'s 2023 MIPS final score plotted against the Pediatric Neurodevelopmental Disabilities Physician national average
- MIPS Final Score
- 80.5085/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Neurodevelopmental Disabilities Physician) — 80.5085/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pediatric Neurodevelopmental Disabilities Physician US NPIs
80.5085/100 MIPS final score — 2.6 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pediatric Neurodevelopmental Disabilities Physician. Quality dim: 80.838. Cost dim: 20.857.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHRISTOPHER GIZA, M.D. is a Pediatric Neurodevelopmental Disabilities Physician provider practicing in LOS ANGELES, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1467488528. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
CHRISTOPHER GIZA, M.D. appears in the CMS NPPES registry as a Pediatric Neurodevelopmental Disabilities Physician provider holding M.D. credentials at 10833 LE CONTE AVE, LOS ANGELES, CA, 90095, with a listed phone of (310) 825-6196. NPI 1467488528 was issued on 06/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GIZA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 44 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $3K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 80.5085/100 for the 2023 performance year (Quality 80.838, Cost 20.857), compared with the national average of 83.1.
Pediatric Neurodevelopmental Disabilities Physician is a narrow specialty nationwide, with 285 enrolled providers across 41 states and an average of 386 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1467488528 |
|---|---|
| Specialty | Pediatric Neurodevelopmental Disabilities Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/23/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHRISTOPHER GIZA, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where CHRISTOPHER GIZA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHRISTOPHER GIZA, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$167
Largest payer
JAZZ PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to CHRISTOPHER GIZA, M.D.. To verify CHRISTOPHER GIZA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 54
- Total Day Supply
- 1,530
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 37.2 years
- Avg HCC Risk Score
- 0.99
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Tizanidine Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Neurodevelopmental Disabilities Physician Overview
How CHRISTOPHER GIZA, M.D. fits within the Pediatric Neurodevelopmental Disabilities Physician landscape nationally.
CHRISTOPHER GIZA, M.D.'s 44 claims are below the specialty average of 386.
Nearby Pediatric Neurodevelopmental Disabilities Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GIZA.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is CHRISTOPHER GIZA, M.D.'s specialty? ▼
How much does CHRISTOPHER GIZA, M.D. prescribe under Medicare Part D? ▼
What is CHRISTOPHER GIZA, M.D.'s Medicare quality score? ▼
Where is CHRISTOPHER GIZA, M.D. located? ▼
What is CHRISTOPHER GIZA, M.D.'s NPI number? ▼
How many Pediatric Neurodevelopmental Disabilities Physician providers are there in the US? ▼
What drugs does CHRISTOPHER GIZA, M.D. prescribe most often? ▼
Does CHRISTOPHER GIZA, M.D. accept Medicare? ▼
How can I verify CHRISTOPHER GIZA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology